AAAAAA
Results: 76-100/265
Authors:
Haapala, K
Lehtimaki, T
Ilveskoski, E
Koivisto, PA
Citation: K. Haapala et al., Apolipoprotein E genotype is not linked to locally recurrent hormone-refractory prostate cancer, PROSTATE C, 3(2), 2000, pp. 107-109
Authors:
Kim, SH
Kim, MS
Jensen, RH
Citation: Sh. Kim et al., Genetic alterations in microdissected prostate cancer cells by comparativegenomic hybridization, PROSTATE C, 3(2), 2000, pp. 110-114
Authors:
Akaza, H
Tsukamoto, S
Morita, T
Yamauchi, A
Onozawa, M
Shimazui, T
Ideyama, Y
Shirai, T
Citation: H. Akaza et al., Promoting effects of antiandrogenic agents on rat ventral prostate carcinogenesis induced by 3,2 '-dimethyl-4-aminobiphenyl (DMAB), PROSTATE C, 3(2), 2000, pp. 115-119
Citation: The British Prostate Group Spring Meeting, 16-17 March 2000, The Swallow Royal Hotel, Bristol - Abstracts, PROSTATE C, 3(2), 2000, pp. 120-129
Authors:
Kirby, R
Scher, H
Brawer, M
Citation: R. Kirby et al., Untitled, PROSTATE C, 3(1), 2000, pp. 5-5
Authors:
Cooper, CR
Pienta, KJ
Citation: Cr. Cooper et Kj. Pienta, Cell adhesion and chemotaxis in prostate cancer metastasis to bone: a minireview, PROSTATE C, 3(1), 2000, pp. 6-12
Authors:
Durkan, GC
Greene, DR
Citation: Gc. Durkan et Dr. Greene, Diagnostic dilemmas in detection of prostate cancer in patients undergoingtransrectal ultrasound-guided needle biopsy of the prostate, PROSTATE C, 3(1), 2000, pp. 13-20
Authors:
Newling, DWW
Citation: Dww. Newling, Tailoring of hormonal therapy in prostate cancer, PROSTATE C, 3(1), 2000, pp. 21-27
Authors:
Mahapokai, W
van Sluijs, FJ
Schalken, JA
Citation: W. Mahapokai et al., Models for studying benign prostatic hyperplasia, PROSTATE C, 3(1), 2000, pp. 28-33
Authors:
Yorukoglu, K
Tuna, B
Kirkali, Z
Citation: K. Yorukoglu et al., Ganglion cells in the human prostate, PROSTATE C, 3(1), 2000, pp. 34-36
Authors:
Adolfsson, J
Oksanen, H
Salo, JO
Steineck, G
Citation: J. Adolfsson et al., Localized prostate cancer and 30 years of follow-up in a population-based setting, PROSTATE C, 3(1), 2000, pp. 37-42
Authors:
Bauer, JJ
Zeng, J
Zhang, W
McLeod, DG
Sesterhenn, IA
Connelly, RR
Mun, SK
Moul, JW
Citation: Jj. Bauer et al., Lateral biopsies added to the traditional sextant prostate biopsy pattern increases the detection rate of prostate cancer, PROSTATE C, 3(1), 2000, pp. 43-46
Authors:
Feneley, MR
Jan, H
Granowska, M
Mather, SJ
Ellison, D
Glass, J
Coptcoat, M
Kirby, RS
Ogden, C
Oliver, RTD
Badenoch, DF
Chinegwundoh, FI
Nargund, VH
Paris, AMI
Britton, KE
Citation: Mr. Feneley et al., Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer, PROSTATE C, 3(1), 2000, pp. 47-52
Authors:
Helal, M
Diaz, JI
Tannenbaum, A
Greenberg, H
Lockhart, J
Citation: M. Helal et al., Postradiation therapy adenosquamous cell carcinoma of the prostate, PROSTATE C, 3(1), 2000, pp. 53-56
Authors:
Belldegrun, A
Citation: A. Belldegrun, What's hot in the prostate?, PROSTATE C, 2(5-6), 1999, pp. 215-217
Authors:
Kirby, R
Brawer, M
Scher, H
Citation: R. Kirby et al., Neural networks - Protein biochip technology - TNF-related apoptosis induction - Prostatitis - Steroid hormones and BPH - Tissue effects of finasteride - Editorial, PROSTATE C, 2(5-6), 1999, pp. 218-218
Authors:
Reckwitz, T
Potter, SR
Snow, PB
Zhang, Z
Veltri, RW
Partin, AW
Citation: T. Reckwitz et al., Artificial neural networks in urology: Update 2000, PROSTATE C, 2(5-6), 1999, pp. 222-226
Authors:
van Ophoven, A
Ng, CP
Patel, B
Bonavida, B
Belldegrun, A
Citation: A. Van Ophoven et al., Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature, PROSTATE C, 2(5-6), 1999, pp. 227-233
Authors:
Theodorou, C
Becopoulos, T
Citation: C. Theodorou et T. Becopoulos, Prostatitis, PROSTATE C, 2(5-6), 1999, pp. 234-240
Authors:
Sedelaar, JPM
de la Rosette, JJMCH
Beerlage, HP
Wijkstra, H
Debruyne, FMJ
Aarnink, RG
Citation: Jpm. Sedelaar et al., Transrectal ultrasound imaging of the prostate: review and perspectives ofrecent developments, PROSTATE C, 2(5-6), 1999, pp. 241-252
Authors:
Brasso, K
Friis, S
Juel, K
Jorgensen, T
Iversen, P
Citation: K. Brasso et al., Morbidity in patients with clinically localized prostate cancer managed with non-curative intent. A population-based case-control study, PROSTATE C, 2(5-6), 1999, pp. 253-256
Authors:
Presnell, SC
Glover, WJ
Borchert, KM
Gregory, CW
Mohler, JL
Smith, GJ
Citation: Sc. Presnell et al., Isolation and partial characterization of an epithelial cell line (RPE-F344) from the regenerating prostate of a normal adult male rat, PROSTATE C, 2(5-6), 1999, pp. 257-263
Authors:
Wright, GL
Cazares, LH
Leung, SM
Nasim, S
Adam, BL
Yip, TT
Schellhammer, PF
Gong, L
Vlahou, A
Citation: Gl. Wright et al., Proteinchip((R)) surface enhanced laser desorption/ionization (SELDI) massspectrometry: a novel protein biochip technology for detection of prostatecancer biomarkers in complex protein mixtures, PROSTATE C, 2(5-6), 1999, pp. 264-276
Authors:
Feneley, MR
Span, PN
Schalken, JA
Harper, M
Griffiths, K
Holmes, K
Kirby, RS
Citation: Mr. Feneley et al., A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia, PROSTATE C, 2(5-6), 1999, pp. 277-281
Authors:
Ead, DN
Koch, M
Smith, JA
Citation: Dn. Ead et al., Is invasive anesthetic monitoring necessary during radical prostatectomy?, PROSTATE C, 2(5-6), 1999, pp. 282-284